LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
Agreement signedPublished 15 Oct 2026

Vivos Therapeutics, Inc. /
SOD Sciences, Inc.

Vivos Therapeutics agrees to swap stock and assets with SOD Sciences

Buy side: Vivos Therapeutics, Inc.
Buy sideVivos Therapeutics, Inc.
Target: SOD Sciences, Inc.
TargetSOD Sciences, Inc.
Vivos Therapeutics, Inc. · 15 Oct 2026Source
See the source
Follow Vivos Therapeutics, Inc. Follow SOD Sciences, Inc.
Buy side: Vivos Therapeutics, Inc.
Buy sideVivos Therapeutics, Inc.
Target: SOD Sciences, Inc.
TargetSOD Sciences, Inc.
01 / BuyerVivos Therapeutics, Inc.
02 / TargetSOD Sciences, Inc.
Source for the buyer and target: Vivos Therapeutics, Inc.

For the buyer and target.

“On October 14, 2026, Vivos Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a Mutual Stock Purchase and Asset Exchange Agreement (the “Agreement”) with SOD Sciences, Inc., a Florida corporation (“SOD”).”

Published 15 Oct 2026

Open the source
01

What happened

Vivos Therapeutics signed a mutual stock purchase and asset exchange agreement with SOD Sciences on Oct. 14, 2026. Under the deal, Vivos would issue a new series of preferred stock to SOD in return for SOD common shares and a 50% co-ownership interest in a pseudohypoxia early-warning test and related intellectual property. The closing is expected on Oct. 15, 2026, and no cash consideration will be paid by either party. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Vivos Therapeutics, Inc.

Vivos Therapeutics agrees to swap stock and assets with SOD Sciences

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Agreement signed

    “Vivos Therapeutics agrees to swap stock and assets with SOD Sciences Vivos Therapeutics signed a mutual stock purchase and asset exchange agreement with SOD Sciences on Oct. 14, 2026”

    Open the source

  2. Expected close

    “The closing is expected on Oct. 15, 2026, and no cash consideration will be paid by either party”

    Open the source

  3. Published by Vivos Therapeutics, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealVivos Therapeutics, Inc. / SOD Sciences, Inc.Agreement signed · Published 15 Oct 2026
BuyerVivos Therapeutics, Inc.TargetSOD Sciences, Inc.
This dealVivos Therapeutics, Inc. / SOD Sciences, Inc.

Agreement signed · Vivos Therapeutics, Inc. / SOD Sciences, Inc. deal (Agreement signed, published 15 Oct 2026).

Agreement signed 14 Oct 2026
Timeline
  1. Agreement signed
  2. Expected close
  3. Published by Vivos Therapeutics, Inc.
Hover or tap a name to see how it connects, and when
Deal Web as a list